Institutional investors purchased a net $2.8 million shares of ANTH during the quarter ended March 2015, and now own 35.59% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PERCEPTIVE ADVISORS LLC Bought 1.1 Million shares of Anthera Pharmaceuticals I...
FRANKLIN ADVISERS, INC. Bought 949.7 Thousand shares of Anthera Pharmaceuticals I...